Table 1.
sICAM-1 concntrations in patients with lung cancer according to clinicopathological features
| Variables | n | sICAM-1 concentration (ng/mL) |
|---|---|---|
| Sex | ||
| Male | 64 | 331.2±128.1 |
| Female | 20 | 316.8±190.0 |
| Age | ||
| <70 | 67 | 327.4±149.5 |
| ≥70 | 17 | 328.6±124.7 |
| Smoking history | ||
| Smoker | 59 | 322.4±127.6 |
| Nonsmoker | 25 | 340.2±179.5 |
| Histologic type | ||
| Non small cell lung cancer | 66 | 327.7±144.4 |
| Adenocarcinoma | 34 | 356.9±130.9 |
| Squamous cell carcinoma | 26 | 321.4±144.5 |
| Others | 6 | 189.9±157.9 |
| Small cell lung cancer | 18 | 327.3±146.9 |
| Stage | ||
| Non small cell lung cancer | ||
| ≤IIIA | 11 | 297.7±80.5 |
| ≥IIIB | 55 | 337.7±153.9 |
| Small cell lung cancer | ||
| limited stage | 4 | 385.0±141.0 |
| extensive stage | 14 | 310.8±149.4 |